Novel biomarkers for glioblastoma brain cancer have been identified in bodily fluids. The discovery may lead to a new, simple, non-invasive blood test to detect brain cancer in the future.
Glioblastoma brain cancer originates from a pool of stem cells that can be a significant distance away from where the tumor eventually forms.
A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients. Researchers say the therapy had a three year survival rate for 21 percent of participants in a phase 1 clinical trial, compared to just 4% of patients who received more standard treatments.
Researchers have identified an abnormal metabolic pathway which drives cancer cell growth in particular glioblastoma brain cancer subtypes.
Glioblastoma stem cells' circadian clocks ramp up the cells' metabolism, making them stronger, more resistant to treatment, and able to divide and multiply more rapidly. By targeting the stem cells with a small molecule drug, researchers found mice models lived longer and their tumors shrank.
A novel helmet that generates a noninvasive oscillating magnetic field was able to reduce tumor mass by 31% in a glioblastoma brain cancer patient.
Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
A new study reports different types of glioblastoma tend to develop in different regions of the brain.
A strain of a bacteria commonly associated with food poisoning could prove an unlikely ally in the battle against glioblastoma brain cancer, a new study reports.
A new study reveals how the physical force exerted by the solid components of brain tumors impacts surrounding tissue, resulting in apoptosis and neurological dysfunction. Researchers reports the drug lithium, commonly prescribed for bipolar disorder, can help reverse some of the damage caused by the solid stress of the tumor.
Disabling the CD161 pathway restores the T-cell's ability to attack gliomas and extends lifespan in animal models of brain cancer.
Using a new algorithm, researchers find the loss of the KLHL9 gene is a driving force behind glioblastoma brain cancer.
